Related by context. Frequent words. (Click for all words.) 76 diagnosed multiple myeloma 65 metastatic hormone refractory 63 HER2 positive metastatic breast 62 metastatic renal cell carcinoma 61 relapsed multiple myeloma 60 relapsed refractory multiple myeloma 60 glioblastoma multiforme GBM 60 randomized #:# 60 Amrubicin 59 plus dexamethasone 59 deforolimus 59 chronic HCV infection 59 chemoradiotherapy 58 CR# vcMMAE 58 dose cohorts 58 chronic HCV 58 pertuzumab 58 Voreloxin 57 neoadjuvant therapy 57 Phase Ib clinical 57 plus prednisone 57 advanced NSCLC 57 azacitidine 57 dacarbazine 57 resistant ovarian cancer 57 IV melanoma 57 HRPC 57 anti TNF alpha 57 Pirfenidone 57 plus gemcitabine 57 Phase 1b clinical 56 Irinotecan 56 Median survival 56 Erlotinib 56 docetaxel 56 SHPT 56 evaluable 56 bone metastases 56 peg IFN 56 HCV infected 56 IRESSA 56 neoadjuvant chemotherapy 56 Phase Ib 56 monotherapy 55 Alemtuzumab 55 median PFS 55 MNTX 55 Gemcitabine 55 Phase 2b study 55 unresectable 55 Fludara 55 nitazoxanide 55 pegylated interferon 55 lymphoma CTCL 55 Bevacizumab 55 Torisel 55 gastrointestinal stromal tumors 55 placebo controlled clinical 55 CoFactor 55 randomized Phase III 55 Phase 1b 55 administered subcutaneously 55 phase IIa 55 active comparator 55 axitinib 55 Acute Myeloid Leukemia AML 55 patients evaluable 55 Phase III randomized 55 blinded placebo controlled 55 Orphan Drug status 55 BAY #-# 55 neoadjuvant 55 romidepsin 54 chronic angina 54 FOLFIRI 54 brain metastases 54 castration resistant prostate cancer 54 IMC A# 54 pazopanib 54 RRMS patients 54 transcriptase inhibitor NNRTI 54 refractory multiple myeloma 54 AA amyloidosis 54 tolerated dose MTD 54 HCV infection 54 double blinded placebo 54 acute myelogenous leukemia AML 54 Phase Ia 54 eltrombopag 54 pancreatic NET 54 Phase 2a clinical 54 evaluable patients 54 Jevtana 54 Trastuzumab 54 liver metastases 54 bone metastasis 54 hepatitis C HCV 54 orphan medicinal product 54 TORISEL 54 Cotara 54 topotecan